Drug Treatment of Pulmonary Hypertension in Children
Author:
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Pediatrics, Perinatology and Child Health
Link
http://link.springer.com/content/pdf/10.1007/s40272-013-0052-2.pdf
Reference176 articles.
1. Rubin LJ. Primary pulmonary hypertension. N Engl J Med. 1997;336(2):111–7.
2. Allen KM, Haworth SG. Cytoskeletal features of immature pulmonary vascular smooth muscle cells: the influence of pulmonary hypertension on normal development. J Pathol. 1989;158(4):311–7.
3. Humbert M, Morrell NW, Archer SL, Stenmark KR, MacLean MR, Lang IM, et al. Cellular and molecular pathobiology of pulmonary arterial hypertension. J Am Coll Cardiol. 2004;43(12 Suppl S):13S–24S.
4. Mandegar M, Fung YC, Huang W, Remillard CV, Rubin LJ, Yuan JX. Cellular and molecular mechanisms of pulmonary vascular remodeling: role in the development of pulmonary hypertension. Microvasc Res. 2004;68(2):75–103.
5. Hassoun PM, Mouthon L, Barbera JA, Eddahibi S, Flores SC, Grimminger F, et al. Inflammation, growth factors, and pulmonary vascular remodeling. J Am Coll Cardiol. 2009;54(1 Suppl):S10–9.
Cited by 42 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Cost-utility of ambrisentan and bosentan for pediatric pulmonary arterial hypertension;Expert Review of Pharmacoeconomics & Outcomes Research;2023-07-07
2. Ambrisentan for in pediatric pulmonary arterial hypertension: A cost‐utility analysis;Pediatric Pulmonology;2023-02-27
3. Pulmonary Hypertension in Congenital Heart Diseases;Congenital Heart Disease in Pediatric and Adult Patients;2023
4. Cardiovascular Pharmacology in Pediatric Patients with Congenital Heart Disease;Congenital Heart Disease in Pediatric and Adult Patients;2023
5. Bosentan Is Associated with a Reduction in Right Ventricular Systolic Pressure N-Terminal Pro-Hormone B-Type Natriuretic Peptide Levels in Young Patients with Pulmonary Hypertension;Open Journal of Pediatrics;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3